CancerVax is a pre-clinical biotech company developing a novel Universal Cancer Treatment platform that will be customizable, as an injection, to treat many types of cancer. Our innovative approach DETECTS, MARKS, and KILLS only cancer cells. By making cancer cells look like well immunized common diseases such as measles or chickenpox, we intend to use the body’s natural immune system to easily kill the cancer cells. We have also created our first cancer drug candidate – a single-disease specific immunotherapy targeting Ewing sarcoma, a rare but deadly bone and soft tissue cancer primarily affecting children and young adults. We look forward to the day when treating cancer will be as simple as getting a shot – a better way to fight cancer.

Our Journey

CancerVax Team

CancerVax is led by an experienced team of biotech experts, cancer researchers and marketing executives, who are working with development partners to create its innovative Universal Cancer Treatment Platform.

Adam Grant, PhD

Principal Scientist

  • An inventor of the Company’s Universal Cancer Treatment platform​
  • Expert computational biologist using AI and machine learning to discover new drugs and biological pathways​
  • Invented software to improve cancer antigen detection​
  • Invented a gene-signature approach to select treatment for breast cancer
Jonathan Lakey, PhD

Chief Scientific Advisor

  • Extensive experience in the fields of oncology, stem cells, and organ transplantation ​
  • An inventor of the famous “Edmonton Protocol” for treating Type 1 diabetes
  • Published over 495 scientific papers, 45 books, and over 500 scientific abstracts
  • Professor Emeritus at University of California, Irvine.
  • Advisor to many biotech companies
Byron Elton

CEO

  • Long career in sales and marketing ​
  • Senior Vice President of Sales for Univision
  • Regional Vice President of Sales for AOL ​
  • Senior Vice President of E-commerce for AOL Canada
Ryan Davies

Chairman Emeritus

  • Extensive background in the biotech industry​
  • Former CEO of Curza, a small molecule antibiotics drug company​
  • Co-founded several biotech companies​
  • Partner in a private equity firm​
  • Served on two U.S. presidential campaigns

The UCLA Research Team

80

Years of collective
experience

health